← ANALYSTS · TIPRANKS
Evan Seigerman · BMO Capital
Hits
59%
289 of 494 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+9.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
22
Buy / hold / sell: 15 / 7 / 0
Upside of the analyst’s targets
+46.5%
Average over 22 current targets, to the last price
The market’s answer to the ratings
−1.5%
Day-0 move against SPY in the rating’s direction, average over 9 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks Oct 13 01:00 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $130 | +15.0% | −1.2%next day −2.4% | ↗ |
| Oct 12on TipRanks 13:20 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $60.00 | +0.4% | −2.5%next day −1.6% | ↗ |
| Oct 12on TipRanks 13:05 | PFESPYPfizer · $168B | Reiterated | Buy | $35.00 | +18.3% | +0.5%next day −0.1% | ↗ |
| Oct 12on TipRanks 12:55 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Buy | $174 | +11.4% | −0.4%next day −1.7% | ↗ |
| Oct 12on TipRanks 09:30 | ABBVSPYAbbVie · $501B | Reiterated | Buy | $300 | +5.1% | +1.7%next day −2.4% | ↗ |
| Oct 12on TipRanks 09:15 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $600 | +20.1% | −0.5%next day −4.3% | ↗ |
| Oct 12on TipRanks 09:15 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $84.00 | +110.5% | −0.5%next day −3.4% | ↗ |
| Oct 12on TipRanks 09:06 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $170 | +16.5% | 0.0%next day −2.4% | ↗ |
| Oct 12on TipRanks 09:06 | BNTXBioNTech SE · $24.1B | Reiterated | Hold | $105 | +19.7% | −1.1%next day −7.1% | ↗ |
| Oct 12on TipRanks 09:00 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $310 | +97.3% | −1.3%next day −5.8% | ↗ |
| Oct 12on TipRanks 08:55 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Buy | $920 | +16.3% | +2.2%next day −1.3% | ↗ |
| Oct 12on TipRanks 08:55 | NBIXNeurocrine · $13.9B | Reiterated | Hold | $164 → $150−8.5% | +10.5% | −0.7%next day −4.4% | ↗ |
| Oct 12on TipRanks 08:55 | NVONovo Nordisk · $170B | Reiterated | Hold | $47.00 → $40.00−14.9% | +3.0% | −0.1%next day −1.3% | ↗ |
| Oct 12on TipRanks 08:55 | SDGRIWMSchrodinger · $1.9B | Reiterated | Buy | $24.00 → $30.00+25.0% | +32.7% | −5.0%next day −0.1% | ↗ |
| Oct 12on TipRanks 08:55 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,400 | +11.4% | +0.3%next day −1.4% | ↗ |
| Oct 12on TipRanks 08:50 | AMGNQQQSPYAmgen · $235B | Reiterated | Hold | $450 → $415−7.8% | −4.0% | +0.7%next day −1.1% | ↗ |
| Oct 12on TipRanks 08:45 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | $208 → $220+5.8% | −5.4% | +1.7%next day −0.2% | ↗ |
| Oct 8on TipRanks 07:35 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $352 → $170−51.7% | +16.5% | +0.1%next day +1.7% · 5 days +2.3% | ↗ |
| Oct 7on TipRanks 08:35 | NVONovo Nordisk · $170B | Reiterated | Hold | $47.00 | +21.0% | +2.2%next day +0.2% · 5 days +0.6% | ↗ |
| Oct 1on TipRanks 07:15 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Buy | $800 → $920+15.0% | +16.3% | −3.3%next day −0.7% · 5 days −0.7% | ↗ |
| Sep 30on TipRanks Oct 1 07:35 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $170 | +16.5% | −2.5%next day −1.2% · 5 days −3.6% | ↗ |
| Sep 30on TipRanks Oct 1 07:35 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $60.00 | +0.4% | −0.5%next day −1.7% · 5 days −5.2% | ↗ |
| Sep 30on TipRanks 09:45 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,400 | +11.4% | −2.1%next day −0.8% · 5 days +0.8% | ↗ |
| Sep 29on TipRanks 07:35 | ABBVSPYAbbVie · $501B | Reiterated | Buy | $300 | +5.1% | −0.9%next day −0.4% · 5 days −0.7% | ↗ |
| Sep 25on TipRanks 09:15 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $170 | +16.5% | 0.0%next day +0.7% · 5 days −2.8% | ↗ |
| Sep 23on TipRanks 07:35 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $600 | +20.1% | +1.0%next day +1.3% · 5 days +1.9% | ↗ |
| Sep 16on TipRanks Sep 17 09:16 | AMGNQQQSPYAmgen · $235B | Reiterated | Hold | $450 | +4.0% | +0.6%next day −0.2% · 5 days +5.8% | ↗ |
| Sep 14on TipRanks Sep 15 10:35 | BNTXBioNTech SE · $24.1B | Reiterated | Hold | $105 | +19.7% | +2.6%next day −1.7% · 5 days −2.8% | ↗ |
| Sep 14on TipRanks 07:40 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $76.00 → $84.00+10.5% | +110.5% | −6.0%next day −3.1% · 5 days −9.0% | ↗ |
| Sep 10on TipRanks Sep 11 08:55 | REPLIWMReplimune Group · $1.1B | Reiterated | Buy | $20.00 | +84.2% | −7.8%next day −3.3% · 5 days −3.4% | ↗ |
| Sep 10on TipRanks Sep 11 08:35 | IRONIWMDisc Medicine · $2.2B | Reiterated | Buy | $100 | +75.9% | −2.5%next day −6.4% · 5 days −7.3% | ↗ |
| Sep 9on TipRanks 10:45 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $60.00 | +0.4% | 0.0%next day −0.4% · 5 days −0.2% | ↗ |
| Sep 9on TipRanks 06:21 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | — | — | −0.4%next day +2.8% · 5 days +3.6% | ↗ |
| Aug 31on TipRanks Sep 1 09:35 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $130 | +15.0% | −0.6%next day +2.1% · 5 days +1.1% | ↗ |
| Aug 30on TipRanks Aug 31 08:05 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $178 | +38.3% | +2.7%next day −0.2% · 5 days −1.1% | ↗ |
| Aug 27on TipRanks Aug 28 08:35 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Buy | $174 | +11.4% | −0.1%next day −1.9% · 5 days +1.3% | ↗ |
| Aug 17on TipRanks Aug 18 07:35 | SDGRIWMSchrodinger · $1.9B | Reiterated | Buy | $24.00 | +6.2% | −0.6%next day +2.2% · 5 days +9.1% | ↗ |
| Aug 17on TipRanks Aug 18 07:35 | PFESPYPfizer · $168B | Reiterated | Buy | $30.00 | +1.4% | +0.8%next day +2.1% · 5 days +5.3% | ↗ |
| Aug 17on TipRanks Aug 18 07:35 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Buy | $800 | +1.2% | +0.8%next day +1.3% · 5 days +4.1% | ↗ |
| Aug 17on TipRanks Aug 18 07:35 | NBIXNeurocrine · $13.9B | Reiterated | Hold | $190 | +40.0% | +1.6%next day +0.5% · 5 days +0.3% | ↗ |
| Aug 13on TipRanks Aug 14 08:15 | MPLTIWMMapLight Therapeutics, Inc. · $446M | Reiterated | Buy | $46.00 → $20.00−56.5% | +159.7% | +1.1%next day +1.7% · 5 days −1.1% | ↗ |
| Jun 30on TipRanks Jul 1 07:52 | TSHAIWMTaysha Gene Therapies · $1.2B | Reiterated | Buy | $14.00 | +286.7% | +0.4%next day −2.2% · 5 days −4.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗